GlassScriptPhysician profile
Jerry D Peterie
NPI 1023014305
$1,618.09
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $515 · 2020: $134 · 2021: $588 · 2022: $226 · 2023: $136 · 2024: $18.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $155.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $551.56 | 2019-2024 | Arikayce |
| Abbvie INC. | $242.60 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $204.49 | 2019-2022 | |
| Allergan, INC. | $140.00 | 2019-2020 | |
| Melinta Therapeutics, LLC | $93.54 | 2019-2022 | |
| Astellas Pharma US INC | $87.83 | 2019-2023 | Cresemba |
| Takeda Pharmaceuticals U.S.A., INC. | $71.85 | 2022 | |
| Gilead Sciences, INC. | $62.09 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $60.90 | 2021 | |
| Mayne Pharma Commercial LLC | $42.82 | 2021 | |
| Vyera Pharmaceuticals, LLC | $19.74 | 2019 | |
| Csl Behring | $17.55 | 2022 | |
| Tactile Systems Technology INC | $11.87 | 2019 | |
| Bio Products Laboratory USA, INC. | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Peterie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.